Financhill
Sell
49

TARA Quote, Financials, Valuation and Earnings

Last price:
$5.48
Seasonality move :
27.06%
Day range:
$5.46 - $5.80
52-week range:
$2.77 - $7.82
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.66x
Volume:
700.5K
Avg. volume:
1M
1-year change:
-8.03%
Market cap:
$219.9M
Revenue:
--
EPS (TTM):
-$1.44

Earnings Data

Next earnings date for TARA
Mar 05
2026
Most recent earnings per share
-$0.31
Beat by $0.07
(Nov 10/2025)
Consensus Estimate
-$0.39
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TARA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 -- -- -- -$0.35 --
11/10/2025 Q3 -- -- -$0.31 -$0.39 $0.07
08/11/2025 Q2 -- -- -$0.35 -$0.41 $0.06
05/01/2025 Q1 -- -- -$0.29 -$0.48 $0.18
03/05/2025 Q4 -- -- -$0.48 -$0.57 $0.08
11/12/2024 Q3 -- -- -$0.50 -$0.52 $0.02
08/06/2024 Q2 -- -- -$0.45 -$0.74 $0.29
05/02/2024 Q1 -- -- -$0.97 -$0.92 -$0.05
03/13/2024 Q4 -- -- -$0.90 -$0.92 $0.02
11/03/2023 Q3 -- -- -$0.87 -$0.98 $0.11
08/03/2023 Q2 -- -- -$1.00 -$0.94 -$0.06
05/04/2023 Q1 -- -- -$0.80 -$0.87 $0.07
03/08/2023 Q4 -- -- -$3.46 -$0.65 -$2.81
11/03/2022 Q3 -- -- -$0.68 -$0.71 $0.02
08/09/2022 Q2 -- -- -$0.80 -$0.78 -$0.02
05/05/2022 Q1 -- -- -$0.96 -$0.77 -$0.19
03/09/2022 Q4 -- -- -$0.91 -$0.81 -$0.11
11/04/2021 Q3 -- -- -$0.96 -$0.96 --
08/05/2021 Q2 -- -- -$1.14 -$0.96 -$0.18
05/06/2021 Q1 -- -- -$1.20 -$0.63 -$0.57
03/11/2021 Q4 -- -- -$0.79 -$0.61 -$0.18
11/12/2020 Q3 -- -- -$1.26 -$0.63 -$0.64
08/03/2020 Q2 -- -- -$1.22 -$0.83 -$0.39
05/13/2020 Q1 -- -- -$1.81 -$0.41 -$1.40
12/31/2019 Q4 -- -- -$1.66 -$0.71 -$0.95
09/30/2019 Q3 -- -- -$2.53 -- --

Protara Therapeutics, Inc. Earnings Questions

  • How Much did Protara Therapeutics, Inc. Generate in Revenue Last Quarter?

    Protara Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Protara Therapeutics, Inc. Beat Earnings Last Quarter?

    Protara Therapeutics, Inc. announced earnings per share of -$0.31 which represents a beat of analyst forecast a -$0.39 per share.

  • Is Protara Therapeutics, Inc. Profitable?

    Protara Therapeutics, Inc. reported -$88K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Protara Therapeutics, Inc. EPS Next Year?

    Protara Therapeutics, Inc.'s earnings are forecast to decrease from -$2.17 per share to -$2.20 per share next year representing a decrease of -37.78%.

  • When is Protara Therapeutics, Inc.'s Earnings Date?

    Protara Therapeutics, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Tesla Stock Go Up In 2026?
Will Tesla Stock Go Up In 2026?

EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…

What Are the Best AI Power Stocks?
What Are the Best AI Power Stocks?

As the construction of AI infrastructure accelerates, the gap between…

Is IONQ The Best Quantum Stock to Buy?
Is IONQ The Best Quantum Stock to Buy?

Riding a wave of investor enthusiasm for the technology, quantum…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 60x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
71
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
37
OKLO alert for Dec 16

Oklo, Inc. [OKLO] is down 5.81% over the past day.

Sell
43
SEI alert for Dec 16

Solaris Energy Infrastructure, Inc. [SEI] is down 5.3% over the past day.

Sell
39
SMX alert for Dec 16

SMX (Security Matters) Plc [SMX] is down 21.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock